Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i
Expression of Fas ligand in retinoblastoma
β Scribed by Subramanian Krishnakumar; Mallikarjuna Kandalam; Adithi Mohan; Anita Iyer; Nalini Venkatesan; Jyotirmay Biswas; Mahesh Palanivelu Shanmugam
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 195 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Whereas the importance of the Fas/FasL system in the regulation of T-cell homeostasis is well established, it is not yet clear if FasL is involved in B-cell regulation, especially in the clonal selection of B lymphocytes in the germinal centre (GC). This study therefore investigated the expression o
## Abstract ## Background. In nasopharyngeal carcinoma (NPC), Fasβligand (FasβL)βmediated apoptosis might contribute to the immune privilege of tumors. In some cancers, dysregulation of FasβL protein in tumors might lead to disease progression. The purpose of this study was to evaluate the correla
It has been postulated that tumor cells expressing Fas ligand (FasL) can evade immune surveillance by inducing apoptosis in T cells expressing Fas. In this study, we investigated FasL expression in 13 human hepatoma cell lines. Strong FasL expression was detected by reverse transcriptionpolymerase c